The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions
Open accessThe DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Abstract
Drug addiction causes constant serious health, social, and economic burden within the human society. The current drug dependence pharmacotherapies, particularly relapse prevention, remain limited, unsatisfactory, unreliable for opioids and tobacco, and even symptomatic for stimulants and cannabinoids, thus, new more effective treatment strategies are researched. The antagonism of the growth hormone secretagogue receptor type A (GHS-R1A) has been recently proposed as a novel alcohol addiction treatment strategy, and it has been intensively studied in experimental models of other addictive drugs, such as nicotine, stimulants, opioids and cannabinoids. The role of ghrelin signaling in these drugs effects has also been investigated. The present review aims to provide a comprehensive overview of preclinical and clinical studies focused on ghrelin’s/GHS-R1A possible involvement in these nonalcohol addictive drugs reinforcing effects and addiction. Although the investigation is still in its early stage, majority of the existing reviewed experimental results from rodents with the addition of few human studies, that searched correlations between the genetic variations of the ghrelin signaling or the ghrelin blood content with the addictive drugs effects, have indicated the importance of the ghrelin’s/GHS-R1As involvement in the nonalcohol abused drugs pro-addictive effects. Further research is necessary to elucidate the exact involved mechanisms and to verify the future potential utilization and safety of the GHS-R1A antagonism use for these drug addiction therapies, particularly for reducing the risk of relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Preclinical studies suggest that ghrelin/GHS-R1a has a significant role in the reinforcing effects of opioids, and in preclinical addiction studies, GHS-R1a antagonism decreased the opioid reward and the symptoms of craving for opioids (139).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ghrelin is a growth-hormone-releasing acylated peptide from stomach
Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., & Kangawa, K. (1999) · Nature · doi:10.1038/45230 · Cited by 8,479 · cited 3×
“The only orexigenic gut-brain peptide hormone, ghrelin, commonly called “hunger hormone”, has been extensively studied for more than 20 years since its discovery [33].”
BackgroundInfluentialThe neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346 · cited 1×
“Furthermore, behavioral sensitization (associated with accumbens dopaminergic sensitization), which is caused by repeated addictive drug administration, is considered within certain limits to be a manifestation of the incentive motivation of underlying drugseeking behavior [18,102,103].”
BackgroundDi Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733 · cited 1×
“Previously, it was suggested that not only the dopamine release in the NAC shell, but the concomitant dopamine release in the VTA and NAC shell might represent a common underlying characteristic induced by various reinforcing stimuli, including natural rewards such as food/water [179], drugs of abuse [12,180,181] and…”
BackgroundNeurobiology of addiction: a neurocircuitry analysis
Koob, G. F., & Volkow, N. D. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00104-8 · Cited by 3,698 · cited 3×
“Drug addiction is a chronic relapsing brain disease triggered by repeated drug exposures in individuals who are vulnerable due to genetic predispositions and developmental or adverse social exposures [5,6].”
BackgroundBardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
Cummings, D. E., Purnell, J. Q., Frayo, R. S., Schmidova, K., Wisse, B. E., & Weigle, D. S. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1714 · Cited by 2,940
A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone Release
Howard, A. D., Feighner, S. D., Cully, D. F., Arena, J. P., Liberator, P. A., Rosenblum, C. I., Hamelin, M., Hreniuk, D. L., Palyha, O. C., Anderson, J., et al. (1996) · Science · doi:10.1126/science.273.5277.974 · Cited by 2,073 · cited 1×
“Acyl-ghrelin mediates its plentiful peripheral as well as central physiological functions through the GHS-R1A, which is encoded by the GHSR gene on chromosome 3 [56,57].”
BackgroundIs there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388
Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,346
Conditioned place preference: what does it add to our preclinical understanding of drug reward?
Bardo, M. T., & Bevins, R. A. (2000) · Psychopharmacology · doi:10.1007/s002130000569 · Cited by 1,241
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
van der Lely, A. J., Tschöp, M., Heiman, M. L., & Ghigo, E. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0029 · Cited by 1,187
Guan, X.-M., Yu, H., Palyha, O. C., McKee, K. K., Feighner, S. D., Sirinathsinghji, D. J. S., Smith, R. G., Van der Ploeg, L. H. T., & Howard, A. D. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00071-5 · Cited by 1,150 · cited 2×
“Acyl-ghrelin mediates its plentiful peripheral as well as central physiological functions through the GHS-R1A, which is encoded by the GHSR gene on chromosome 3 [56,57].”
BackgroundThe Neuroscience of Natural Rewards: Relevance to Addictive Drugs
Kelley, A. E., & Berridge, K. C. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03306.2002 · Cited by 1,123
Expression of ghrelin receptor mRNA in the rat and the mouse brain
Zigman, J. M., Jones, J. E., Lee, C. E., Saper, C. B., & Elmquist, J. K. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20823 · Cited by 1,074
Müller, T. D., Nogueiras, R., Andermann, M. L., Andrews, Z. B., Anker, S. D., Argente, J., Batterham, R. L., Benoit, S. C., Bowers, C. Y., Broglio, F., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.03.005 · Cited by 1,034
Nucleus accumbens shell and core dopamine: differential role in behavior and addiction
Di Chiara, G. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00286-3 · Cited by 996
Abizaid, A., Liu, Z.-W., Andrews, Z. B., Shanabrough, M., Borok, E., Elsworth, J. D., Roth, R. H., Sleeman, M. W., Picciotto, M. R., Tschöp, M. H., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29867 · Cited by 984 · cited 1×
“The systemic and central (into the VTA) administration of acyl-ghrelin induced the dopamine release in the NAC (shell) and locomotor hyperactivity in rodents [61,64,82,84,85].”
BackgroundThe Neuroscience of Drug Reward and Addiction
Volkow, N. D., Michaelides, M., & Baler, R. (2019) · Physiological Reviews · doi:10.1152/physrev.00014.2018 · Cited by 863 · cited 2×
“Drug addiction is a chronic relapsing brain disease triggered by repeated drug exposures in individuals who are vulnerable due to genetic predispositions and developmental or adverse social exposures [5,6].”
BackgroundTHE SUBMITOCHONDRIAL LOCALIZATION OF MONOAMINE OXIDASE
Schnaitman, C., Erwin, V. G., & Greenawalt, J. W. (1967) · The Journal of Cell Biology · doi:10.1083/jcb.32.3.719 · Cited by 837
Obesity and addiction: Neurobiological overlaps
Volkow, N. D., Wang, G. ‐., Tomasi, D., & Baler, R. D. (2013) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01031.x · Cited by 800 · cited 1×
“There is a noticeable overlap of involved neuronal systems [27] as well as a high comorbidity between eating disorders and substance use disorders [28].”
BackgroundRole of mitochondrial ROS in the brain: from physiology to neurodegeneration
Angelova, P. R., & Abramov, A. Y. (2018) · FEBS Letters · doi:10.1002/1873-3468.12964 · Cited by 789
Catecholamine theories of reward: A critical review
Wise, R. A. (1978) · Brain Research · doi:10.1016/0006-8993(78)90253-6 · Cited by 766
Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas
Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002) · Neuron · doi:10.1016/s0896-6273(02)00625-6 · Cited by 701
Drug Wanting: Behavioral Sensitization and Relapse to Drug-Seeking Behavior
Steketee, J. D., & Kalivas, P. W. (2011) · Pharmacological Reviews · doi:10.1124/pr.109.001933 · Cited by 650
Neurobiology of the incubation of drug craving
Pickens, C. L., Airavaara, M., Theberge, F., Fanous, S., Hope, B. T., & Shaham, Y. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.06.001 · Cited by 642
Drug addiction as dopamine-dependent associative learning disorder
Di Chiara, G. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00372-6 · Cited by 596
Farsalinos, K. E., & Polosa, R. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614524430 · Cited by 594
Dopamine and reward: The anhedonia hypothesis 30 years on
Wise, R. A. (2008) · Neurotoxicity Research · doi:10.1007/bf03033808 · Cited by 580
Involvement of the endocannabinoid system in drug addiction
Maldonado, R., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 580
US epidemiology of cannabis use and associated problems
Hasin, D. S. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.198 · Cited by 578
Cummings, D. E., Frayo, R. S., Marmonier, C., Aubert, R., & Chapelot, D. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00582.2003 · Cited by 527 · cited 2×
“, feeding state [38,39,156]; mood and stress factors, including stress history (e.”
BackgroundResultInfluentialCo-morbidity of eating disorders and substance abuse review of the literature
Holderness, C. C., Brooks-Gunn, J., & Warren, M. P. (1994) · International Journal of Eating Disorders · doi:10.1002/1098-108x(199407)16:1<1::aid-eat2260160102>3.0.co;2-t · Cited by 490 · cited 1×
“There is a noticeable overlap of involved neuronal systems [27] as well as a high comorbidity between eating disorders and substance use disorders [28].”
BackgroundSora, I., Hall, F. S., Andrews, A. M., Itokawa, M., Li, X.-F., Wei, H.-B., Wichems, C., Lesch, K.-P., Murphy, D. L., & Uhl, G. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091039298 · Cited by 477
Fields, H. L., & Margolis, E. B. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.01.002 · Cited by 432
The role of reward pathways in the development of drug dependence
Wise, R. A. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90108-2 · Cited by 432 · cited 1×
“), which is considered to be a sign of nigrostriatal dopaminergic pathway activation [6,19].”
BackgroundJerlhag, E., Egecioglu, E., Dickson, S. L., Douhan, A., Svensson, L., & Engel, J. A. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00041.x · Cited by 431 · cited 2×
“The injection of acyl-ghrelin into the LDTg, where the GHS-R1As are located on the cholinergic neurons, also stimulated the locomotor activity, caused accumbens dopamine efflux, and concomitantly enhanced the levels of the VTA-acetylcholine via the nicotinic cholinergic receptor (nAChR)-dependent mechanism [55,84].”
BackgroundRequirement of central ghrelin signaling for alcohol reward
Jerlhag, E., Egecioglu, E., Landgren, S., Salomé, N., Heilig, M., Moechars, D., Datta, R., Perrissoud, D., Dickson, S. L., & Engel, J. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812809106 · Cited by 424 · cited 1×
“Initial preclinical experiments explored and evidenced the ghrelin’s involvement in the processing of reinforcing effects of alcohol, which can be considered both a palatable food and energy resource and an addictive substance [92].”
BackgroundNaleid, A. M., Grace, M. K., Cummings, D. E., & Levine, A. S. (2005) · Peptides · doi:10.1016/j.peptides.2005.04.025 · Cited by 409 · cited 1×
“Initial experiments noted, that the μ-receptor antagonist naltrexone did not attenuate ghrelin-induced food intake [35] nor ghrelin-induced locomotor stimulation [83], which indicated, that μ-receptors do not play any role in the ghrelin effects.”
BackgroundMello, N. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00274-h · Cited by 392
Functional interaction between opioid and cannabinoid receptors in drug self-administration.
Navarro, M., Carrera, M. R. A., Fratta, W., Valverde, O., Cossu, G., Fattore, L., Chowen, J. A., Gómez, R., del Arco, I., Villanúa, M. A., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05344.2001 · Cited by 378
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor
Ge, X., Yang, H., Bednarek, M. A., Galon-Tilleman, H., Chen, P., Chen, M., Lichtman, J. S., Wang, Y., Dalmas, O., Yin, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.016 · Cited by 376
Jerlhag, E., Egecioglu, E., Dickson, S. L., Andersson, M., Svensson, L., & Engel, J. A. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00002.x · Cited by 352
Carlini, V. P., Varas, M. M., Cragnolini, A. B., Schiöth, H. B., Scimonelli, T. N., & de Barioglio, S. R. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.150 · Cited by 341
Ghrelin directly targets the ventral tegmental area to increase food motivation
Skibicka, K. P., Hansson, C., Alvarez-Crespo, M., Friberg, P. A., & Dickson, S. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.02.016 · Cited by 334
PRECLINICAL STUDY: FULL ARTICLE: Ghrelin increases intake of rewarding food in rodents
Egecioglu, E., Jerlhag, E., Salomé, N., Skibicka, K. P., Haage, D., Bohlooly‐Y, M., Andersson, D., Bjursell, M., Perrissoud, D., Engel, J. A., et al. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00216.x · Cited by 332 · cited 1×
“, substances of different effects and structures), together with previously published studies on the participation of ghrelin/GHS-R1As in food reinforcement [34,197], and cue-induced palatable food-intake reinstatement [230], and similar findings from alcoholghrelin/GHS-R1A studies [26,231], indicate that ghrelin and…”
ResultSakata, I., Nakamura, K., Yamazaki, M., Matsubara, M., Hayashi, Y., Kangawa, K., & Sakai, T. (2002) · Peptides · doi:10.1016/s0196-9781(01)00633-7 · Cited by 325
Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons
Schaeffer, M., Langlet, F., Lafont, C., Molino, F., Hodson, D. J., Roux, T., Lamarque, L., Verdié, P., Bourrier, E., Dehouck, B., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212137110 · Cited by 325
Kola, B., Farkas, I., Christ-Crain, M., Wittmann, G., Lolli, F., Amin, F., Harvey-White, J., Liposits, Z., Kunos, G., Grossman, A. B., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001797 · Cited by 295
Caillé, S., Alvarez-Jaimes, L., Polis, I., Stouffer, D. G., & Parsons, L. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4403-06.2007 · Cited by 280
Forster, G. L., & Blaha, C. D. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00250.x · Cited by 271
Neural Systems Underlying Opiate Addiction
De Vries, T. J., & Shippenberg, T. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03321.2002 · Cited by 270
Immunocytochemical observation of ghrelin-containing neurons in the rat arcuate nucleus
Lu, S., Guan, J.-L., Wang, Q.-P., Uehara, K., Yamada, S., Goto, N., Date, Y., Nakazato, M., Kojima, M., Kangawa, K., et al. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02544-7 · Cited by 268
Skibicka, K. P., Hansson, C., Egecioglu, E., & Dickson, S. L. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00294.x · Cited by 253
Cannabis Addiction and the Brain: a Review
Zehra, A., Burns, J., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G.-J. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9782-9 · Cited by 249
Ghrelin regulates the hypothalamic-pituitary-adrenal axis and restricts anxiety after acute stress
Spencer, S. J., Xu, L., Clarke, M. A., Lemus, M., Reichenbach, A., Geenen, B., Kozicz, T., & Andrews, Z. B. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.010 · Cited by 241
MECHANISMS IN ENDOCRINOLOGY: Ghrelin: the differences between acyl- and des-acyl ghrelin
Delhanty, P. J. D., Neggers, S. J., & van der Lely, A. J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0456 · Cited by 237
Sellings, L. H. L., & Clarke, P. B. S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06295.2003 · Cited by 233
VTA GABA Neurons at the Interface of Stress and Reward
Bouarab, C., Thompson, B., & Polter, A. M. (2019) · Frontiers in Neural Circuits · doi:10.3389/fncir.2019.00078 · Cited by 223
Spanagel, R. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/rspanagel · Cited by 221
Neurochemical and behavioral studies on ethanol and nicotine interactions
Larsson, A., & Engel, J. A. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.11.010 · Cited by 220
Jerlhag, E., Egecioglu, E., Dickson, S. L., & Engel, J. A. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1907-7 · Cited by 216
Robertson, S. D., Matthies, H. J. G., & Galli, A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8053-4 · Cited by 205
Neural Systems Governed by Nicotinic Acetylcholine Receptors: Emerging Hypotheses
Miwa, J. M., Freedman, R., & Lester, H. A. (2011) · Neuron · doi:10.1016/j.neuron.2011.03.014 · Cited by 205
Stress and relapse to drug seeking in rats: studies on the generality of the effect
Shalev, U., Highfield, D., Yap, J., & Shaham, Y. (2000) · Psychopharmacology · doi:10.1007/s002130000441 · Cited by 197
The Hypothalamic Mechanisms of the Hypophysiotropic Action of Ghrelin
Wren, A. M., Small, C. J., Fribbens, C. V., Neary, N. M., Ward, H. L., Seal, L. J., Ghatei, M. A., & Bloom, S. R. (2002) · Neuroendocrinology · doi:10.1159/000066629 · Cited by 191
Ferrini, F., Salio, C., Lossi, L., & Merighi, A. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602779 · Cited by 191 · cited 15×
“Gradually, the possible relationships between ghrelin/GHS-R1As and several other drugs of abuse have also been explored, and many interesting results have already been assembled in several reviews [26,99–101].”
BackgroundInfluentialM’Kadmi, C., Cabral, A., Barrile, F., Giribaldi, J., Cantel, S., Damian, M., Mary, S., Denoyelle, S., Dutertre, S., Péraldi-Roux, S., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01644 · Cited by 187 · cited 1×
“Recently, the liver-expressed antimicrobial peptide 2 (LEAP2) was described as an endogenous antagonist/inverse agonist of the GHS-R1A which regulates the transmission of intracellular signals from ghrelin [58,80,81].”
BackgroundFood Restriction Enhances the Central Rewarding Effect of Abused Drugs
Cabeza de Vaca, S., & Carr, K. D. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07502.1998 · Cited by 185 · cited 1×
“Food restriction (FR) increases stimulant (amphetamine, D1 agonist A77636) consumption and signs of reward [30,31], and increases amphetamine/cocaine intake and the reinstatement of drug-seeking behavior [153,154].”
BackgroundTucci, S. A., Rogers, E. K., Korbonits, M., & Kirkham, T. C. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705968 · Cited by 183
Bradberry, C. W., & Roth, R. H. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90492-8 · Cited by 183
Klitenick, M. A., Deutch, A. Y., Churchill, L., & Kalivas, P. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90430-a · Cited by 182
Chronic food restriction: Enhancing effects on drug reward and striatal cell signaling
Carr, K. D. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.09.021 · Cited by 180
Li, Y., Acerbo, M. J., & Robinson, T. E. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03612.x · Cited by 180
Yoshida, M., Yokoo, H., Mizoguchi, K., Kawahara, H., Tsuda, A., Nishikawa, T., & Tanaka, M. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90861-z · Cited by 179
DI CHIARA, G., & IMPERATO, A. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb23629.x · Cited by 177
Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus
Mondal, M. S., Date, Y., Yamaguchi, H., Toshinai, K., Tsuruta, T., Kangawa, K., & Nakazato, M. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.038 · Cited by 176
Barrett, S. P., Boileau, I., Okker, J., Pihl, R. O., & Dagher, A. (2004) · Synapse · doi:10.1002/syn.20066 · Cited by 173
E-Cigarettes are More Addictive than Traditional Cigarettes—A Study in Highly Educated Young People
Jankowski, M., Krzystanek, M., Zejda, J. E., Majek, P., Lubanski, J., Lawson, J. A., & Brozek, G. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16132279 · Cited by 171
Van Ree, J. M., Niesink, R. J. M., Van Wolfswinkel, L., Ramsey, N. F., Kornet, M. (. ). M. W., Van Furth, W. R., Vanderschuren, L. J. M. J., Gerrits, M. A. F. M., & Van den Berg, C. L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00544-6 · Cited by 166
Interaction of Amphetamines and Related Compounds at the Vesicular Monoamine Transporter
Partilla, J. S., Dempsey, A. G., Nagpal, A., Blough, B. E., Baumann, M. H., & Rothman, R. B. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.103622 · Cited by 161
Schellekens, H., van Oeffelen, W. E. P. A., Dinan, T. G., & Cryan, J. F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382473 · Cited by 152 · cited 2×
“However, the functional role of GHS-R1B still remains much less explored [74,78,79].”
BackgroundDon't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward
Volkow, N. D., Hampson, A. J., & Baler, R. D. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104615 · Cited by 152 · cited 1×
“Beside other roles, endocannabinoid system participates significantly in metabolism and homeostatic as well as hedonic food intake and drug abuse [22,221,223,224].”
BackgroundCarroll, M. E. (1985) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(85)90109-7 · Cited by 143
Jerlhag, E., & Engel, J. A. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.01.010 · Cited by 142
Krahn, D. D., Kurth, C., Demitrack, M. A., & Drewnowski, A. (1992) · Journal of Substance Abuse · doi:10.1016/0899-3289(92)90041-u · Cited by 137 · cited 1×
“The prevalence of substance use was found to be increased with food restriction/dieting severity [29], and food restriction was found to enhance the central rewarding effects of abused drugs [30–32], which inspired the investigation into the involvement of appetite regulating substances in drug addiction.”
BackgroundQuarta, D., Francesco, C. D., Melotto, S., Mangiarini, L., Heidbreder, C. A., & Hédou, G. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2008.12.006 · Cited by 137 · cited 1×
“The systemic and central (into the VTA) administration of acyl-ghrelin induced the dopamine release in the NAC (shell) and locomotor hyperactivity in rodents [61,64,82,84,85].”
BackgroundHARRIS, S. C. (1947) · Journal of the American Medical Association · doi:10.1001/jama.1947.02880340022005 · Cited by 136
Engel, J. A., & Jerlhag, E. (2014) · CNS Drugs · doi:10.1007/s40263-014-0178-y · Cited by 132
Ghrelin and food reward: The story of potential underlying substrates
Skibicka, K. P., & Dickson, S. L. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.016 · Cited by 132
Grigson, P. S. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00758-8 · Cited by 130
Spencer, S. J., Emmerzaal, T. L., Kozicz, T., & Andrews, Z. B. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.021 · Cited by 129
Lee, M. R., Tapocik, J. D., Ghareeb, M., Schwandt, M. L., Dias, A. A., Le, A. N., Cobbina, E., Farinelli, L. A., Bouhlal, S., Farokhnia, M., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0064-y · Cited by 129 · cited 5×
“We did not focus on alcohol-ghrelin relationship, as the most advanced and extensive research into ghrelin-alcohol interactions was recently reviewed elsewhere [26,93,95], including the initial human study that tested one GHS-R1A inverse agonist in alcohol addicts; thus, we only mentioned the latest clinical results o…”
BackgroundMethodInfluentialOmelchenko, N., & Sesack, S. R. (2006) · Journal of Comparative Neurology · doi:10.1002/cne.20852 · Cited by 127 · cited 1×
“Converging evidence indicates that the excitatory cholinergic terminals in the VTA that arise from the laterodorsal tegmental area (LDTg) synapse on the VTA-dopaminergic neurons, which preferentially innervate the NAC [14].”
BackgroundRole of the endocannabinoid system in drug addiction
Manzanares, J., Cabañero, D., Puente, N., García‐Gutiérrez, M. S., Grandes, P., & Maldonado, R. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.013 · Cited by 127
Augmentation of cocaine hyperactivity in rats by systemic ghrelin
Wellman, P. J., Davis, K. W., & Nation, J. R. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.013 · Cited by 125
Farokhnia, M., Grodin, E. N., Lee, M. R., Oot, E. N., Blackburn, A. N., Stangl, B. L., Schwandt, M. L., Farinelli, L. A., Momenan, R., Ramchandani, V. A., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.226 · Cited by 125
Investigation of the presence of ghrelin in the central nervous system of the rat and mouse
Furness, J. B., Hunne, B., Matsuda, N., Yin, L., Russo, D., Kato, I., Fujimiya, M., Patterson, M., McLeod, J. L., Andrews, Z. B., et al. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.063 · Cited by 124
Endocannabinoid system and opioid addiction: Behavioural aspects
Fattore, L., Deiana, S., Spano, S., Cossu, G., Fadda, P., Scherma, M., & Fratta, W. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.031 · Cited by 122
The autonomic nervous system regulates gastric ghrelin secretion in rats
Hosoda, H., & Kangawa, K. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.07.005 · Cited by 121
Who Smokes in Europe? Data From 12 European Countries in the TackSHS Survey (2017–2018)
Gallus, S., Lugo, A., Liu, X., BEHRAKIS, P. K., Boffi, R., Bosetti, C., Carreras, G., Chatenoud, L., Clancy, L., Continente, X., et al. (2020) · Journal of Epidemiology · doi:10.2188/jea.je20190344 · Cited by 121
Ghrelin in psychiatric disorders – A review
Wittekind, D. A., & Kluge, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.11.013 · Cited by 120
Pharmacology of appetite suppression
Halford, J. C. G., & Blundell, J. E. (2000) · Progress in Drug Research · doi:10.1007/978-3-0348-8391-7_2 · Cited by 119
Heppner, K. M., Piechowski, C. L., Müller, A., Ottaway, N., Sisley, S., Smiley, D. L., Habegger, K. M., Pfluger, P. T., DiMarchi, R., Biebermann, H., et al. (2014) · Diabetes · doi:10.2337/db13-0414 · Cited by 119
Effect of Food Restriction on Ghrelin in Normal‐Cycling Female Rats and in Pregnancy
Gualillo, O., Caminos, J. E., Nogueiras, R., Seoane, L. M., Arvat, E., Ghigo, E., Casanueva, F. F., & Diéguez, C. (2002) · Obesity Research · doi:10.1038/oby.2002.92 · Cited by 118
Rhea, E. M., Salameh, T. S., Gray, S., Niu, J., Banks, W. A., & Tong, J. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.09.007 · Cited by 114 · cited 1×
“Both ghrelin forms are detectable in the blood circulation and can pass through the blood brain barrier to the brain [49,50].”
BackgroundAugmented cocaine conditioned place preference in rats pretreated with systemic ghrelin
Davis, K. W., Wellman, P. J., & Clifford, P. S. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2006.12.003 · Cited by 113
Monoamine Oxidase and Mitochondrial Respiration
Cohen, G., & Kesler, N. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732310.x · Cited by 113
Concomitant Release of Ventral Tegmental Acetylcholine and Accumbal Dopamine by Ghrelin in Rats
Jerlhag, E., Janson, A. C., Waters, S., & Engel, J. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049557 · Cited by 113 · cited 3×
“Additionally, the peripheral injection of acyl-ghrelin induced the concomitant release of VTA acetylcholine and accumbens dopamine [55].”
BackgroundIs Ghrelin Synthesized in the Central Nervous System?
Cabral, A., López Soto, E., Epelbaum, J., & Perelló, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030638 · Cited by 112 · cited 2×
“The notion that ghrelin can be produced in the central nervous system of mammals in physiologically relevant levels still remains controversial [43].”
BackgroundJerlhag, E., Egecioglu, E., Dickson, S. L., & Engel, J. A. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00231.x · Cited by 108 · cited 2×
“Initial experiments noted, that the μ-receptor antagonist naltrexone did not attenuate ghrelin-induced food intake [35] nor ghrelin-induced locomotor stimulation [83], which indicated, that μ-receptors do not play any role in the ghrelin effects.”
BackgroundFagerberg, B., Hultén, L. M., & Hulthe, J. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00274-9 · Cited by 108
Cabral, A., Valdivia, S., Fernandez, G., Reynaldo, M., & Perello, M. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12168 · Cited by 107 · cited 1×
“Both ghrelin forms are detectable in the blood circulation and can pass through the blood brain barrier to the brain [49,50].”
BackgroundAgonism, Antagonism, and Inverse Agonism Bias at the Ghrelin Receptor Signaling
M'Kadmi, C., Leyris, J.-P., Onfroy, L., Galés, C., Saulière, A., Gagne, D., Damian, M., Mary, S., Maingot, M., Denoyelle, S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.659250 · Cited by 107
Holliday, N. D., Holst, B., Rodionova, E., Schwartz, T. W., & Cox, H. M. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0254 · Cited by 106
Heterogeneity of Ghrelin/Growth Hormone Secretagogue Receptors
Muccioli, G., Baragli, A., Granata, R., Papotti, M., & Ghigo, E. (2007) · Neuroendocrinology · doi:10.1159/000105141 · Cited by 104 · cited 1×
“However, the functional role of GHS-R1B still remains much less explored [74,78,79].”
BackgroundFarokhnia, M., McDiarmid, G. R., Newmeyer, M. N., Munjal, V., Abulseoud, O. A., Huestis, M. A., & Leggio, L. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0756-3 · Cited by 104
Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder
Farokhnia, M., Faulkner, M. L., Piacentino, D., Lee, M. R., & Leggio, L. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.02.008 · Cited by 103 · cited 3×
“Nonetheless, this should be expected, considering that the research is still in its early preclinical phase and that the only orally applicable ghrelin antagonist/inverse agonist that has demonstrated sufficient safety for use in clinical testing has only just been used in human studies for the first time [94,95,97,98…”
BackgroundCallaghan, B. P., & Furness, J. B. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008433 · Cited by 102 · cited 1×
“, D1R), promoting profound qualitative changes in ghrelin-induced signaling [47,76,77].”
BackgroundCocaine-Conditioned Place Preference by Dopamine-Deficient Mice Is Mediated by Serotonin
Hnasko, T. S., Sotak, B. N., & Palmiter, R. D. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3133-07.2007 · Cited by 99
Currie, P. J., Khelemsky, R., Rigsbee, E. M., Dono, L. M., Coiro, C. D., Chapman, C. D., & Hinchcliff, K. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.037 · Cited by 97
Increased Mesolimbic GABA Concentration Blocks Heroin Self-Administration in the Rat
Xi, Z.-X., & Stein, E. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39113-x · Cited by 96
Suchankova, P., Steensland, P., Fredriksson, I., Engel, J. A., & Jerlhag, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071284 · Cited by 95
The Role of the Ghrelin System in Drug Addiction
Zallar, L. J., Farokhnia, M., Tunstall, B. J., Vendruscolo, L. F., & Leggio, L. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.08.002 · Cited by 94
Tessari, M., Catalano, A., Pellitteri, M., Francesco, C. D., Marini, F., Gerrard, P. A., Heidbreder, C. A., & Melotto, S. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00052.x · Cited by 93
Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse
Jerlhag, E. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.005 · Cited by 93 · cited 6×
“, through cholinergic neurons or orexin-containing neurons projecting from hypothalamus to these rewardrelated areas) [26,55].”
BackgroundResultInfluentialThe Central Nervous System Sites Mediating the Orexigenic Actions of Ghrelin
Mason, B. L., Wang, Q., & Zigman, J. M. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170310 · Cited by 91
The pharmacokinetics of acyl, des-acyl, and total ghrelin in healthy human subjects
Tong, J., Dave, N., Mugundu, G. M., Davis, H. W., Gaylinn, B. D., Thorner, M. O., Tschöp, M. H., D'Alessio, D., & Desai, P. B. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0072 · Cited by 89
A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men
Riggs, P. K., Vaida, F., Rossi, S. S., Sorkin, L. S., Gouaux, B. D., Grant, I., & Ellis, R. J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.001 · Cited by 87
Growth Hormone Secretagogue Receptor Dimers: A New Pharmacological Target
Wellman, M., & Abizaid, A. (2015) · eneuro · doi:10.1523/eneuro.0053-14.2015 · Cited by 86 · cited 5×
“A clear interaction between ghrelin and cannabinoid mesolimbic signaling was documented by a study wherein systemic pretreatment with the CB1R antagonist/rimonabant significantly reduced intracerebroventricular ghrelin-induced NAC dopamine release and hyperlocomotion in mice [228].”
BackgroundInfluentialLandgren, S., Engel, J. A., Hyytiä, P., Zetterberg, H., Blennow, K., & Jerlhag, E. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.03.003 · Cited by 84
The "Stop" and "Go" of Nicotine Dependence: Role of GABA and Glutamate
D’Souza, M. S., & Markou, A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012146 · Cited by 83
Brain accessibility delineates the central effects of circulating ghrelin
Perello, M., Cabral, A., Cornejo, M. P., De Francesco, P. N., Fernandez, G., & Uriarte, M. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12677 · Cited by 82 · cited 3×
“Previously, it was suggested that not only the dopamine release in the NAC shell, but the concomitant dopamine release in the VTA and NAC shell might represent a common underlying characteristic induced by various reinforcing stimuli, including natural rewards such as food/water [179], drugs of abuse [12,180,181] and…”
BackgroundGHS-R1a constitutive activity and its physiological relevance
Mear, Y., Enjalbert, A., & Thirion, S. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00087 · Cited by 80
Ghrelin and the Metabolic Syndrome in Older Adults
Langenberg, C., Bergstrom, J., Laughlin, G. A., & Barrett-Connor, E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1358 · Cited by 80
Clifford, P. S., Rodriguez, J., Schul, D., Hughes, S., Kniffin, T., Hart, N., Eitan, S., Brunel, L., Fehrentz, J., Martinez, J., et al. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00339.x · Cited by 80
An Integrative Review on Role and Mechanisms of Ghrelin in Stress, Anxiety and Depression
Bali, A., & Singh Jaggi, A. (2016) · Current Drug Targets · doi:10.2174/1389450116666150518095650 · Cited by 80
Ghrelin is a persistent biomarker for chronic stress exposure in adolescent rats and humans
Yousufzai, M. I. U. A., Harmatz, E. S., Shah, M., Malik, M. O., & Goosens, K. A. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0135-5 · Cited by 79
Increased leptin and decreased ghrelin level after smoking cessation
Lee, H., Joe, K., Kim, W. B., Park, J.-W., Lee, D. H., Sung, K.-W., & Kim, D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.013 · Cited by 78
Pharmacotoxicology of Non-fentanyl Derived New Synthetic Opioids
Solimini, R., Pichini, S., Pacifici, R., Busardò, F. P., & Giorgetti, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00654 · Cited by 75
Moulin, A., Brunel, L., Boeglin, D. R., Demange, L., Ryan, J. L., M’Kadmi, C., Denoyelle, S., Martínez, J., & Fehrentz, J. (2012) · Amino Acids · doi:10.1007/s00726-012-1355-2 · Cited by 74
Reduced locomotor responses to cocaine in ghrelin-deficient mice
Abizaid, A. B., Mineur, Y. S., Roth, R. H., Elsworth, J. D., Sleeman, M., Picciotto, M. R., & Horváth, T. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.001 · Cited by 74
Oral d-amphetamine and ketamine self-administration by rhesus monkeys: effects of food deprivation.
Carroll, M. E., & Stotz, D. C. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22027-4 · Cited by 74
Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism
Lim, C. T., Kola, B., Feltrin, D., Pérez–Tilve, D., Tschöp, M. H., Grossman, A. B., & Korbonits, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.11.007 · Cited by 73
Ghrelin Signaling: GOAT and GHS-R1a Take a LEAP in Complexity
Abizaid, A., & Hougland, J. L. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.09.006 · Cited by 73 · cited 3×
“Furthermore, another variant of the ghrelin receptor, GHS-R1B, forms heterodimers/oligomeric complexes with the GHS-R1A and acts as a dual modulator of its functions [58,76].”
BackgroundShould We Consider Des-Acyl Ghrelin as a Separate Hormone and If So, What Does It Do?
Delhanty, P. J. D., Neggers, S. J., & van der Lely, A. J. (2014) · Frontiers of Hormone Research · doi:10.1159/000358345 · Cited by 71 · cited 1×
“(without the n-octanoyl moiety) represents the majority form of ghrelin in the blood and behaves as a separate hormone with a number of physiological functions [44,45].”
BackgroundGhrelin fluctuation, what determines its production?
Yin, X., Li, Y., Xu, G., An, W., & Zhang, W. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp001 · Cited by 70
Hopkins, A. L., Nelson, T. A. S., Guschina, I. A., Parsons, L. C., Lewis, C. L., Brown, R. C., Christian, H. C., Davies, J. S., & Wells, T. (2017) · Scientific Reports · doi:10.1038/srep45541 · Cited by 70 · cited 1×
“(without the n-octanoyl moiety) represents the majority form of ghrelin in the blood and behaves as a separate hormone with a number of physiological functions [44,45].”
BackgroundThe Growth Hormone Secretagogue Receptor
Cruz, C. C., & Smith, R. G. (2007) · Vitamins and hormones · doi:10.1016/s0083-6729(06)77004-2 · Cited by 70
The role of ghrelin in addiction: a review
Panagopoulos, V. N., & Ralevski, E. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3640-0 · Cited by 69
Carr, K. D., Kim, G.-Y., & de Vaca, S. C. (2001) · Psychopharmacology · doi:10.1007/s002130000674 · Cited by 68 · cited 1×
“Food restriction (FR) increases stimulant (amphetamine, D1 agonist A77636) consumption and signs of reward [30,31], and increases amphetamine/cocaine intake and the reinstatement of drug-seeking behavior [153,154].”
BackgroundKawahara, Y., Kaneko, F., Yamada, M., Kishikawa, Y., Kawahara, H., & Nishi, A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.022 · Cited by 68
Pharmacotherapy for the Treatment of Cannabis Use Disorder: A Systematic Review
Kondo, K. K., Morasco, B. J., Nugent, S. M., Ayers, C. K., O'Neil, M. E., Freeman, M., & Kansagara, D. L. (2020) · Annals of Internal Medicine · doi:10.7326/m19-1105 · Cited by 67
Ghrelin-Derived Peptides: A Link between Appetite/Reward, GH Axis, and Psychiatric Disorders?
Labarthe, A., Fiquet, O., Hassouna, R., Zizzari, P., Lanfumey, L., Ramoz, N., Grouselle, D., Epelbaum, J., & Tolle, V. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00163 · Cited by 66
Engel, J. A., Nylander, I., & Jerlhag, E. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.10.004 · Cited by 66
Systemic ghrelin sensitizes cocaine-induced hyperlocomotion in rats
Wellman, P. J., Hollas, C. N., & Elliott, A. E. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.07.007 · Cited by 62
Ghrelin as a Stress Hormone: Implications for Psychiatric Illness
Stone, L. A., Harmatz, E. S., & Goosens, K. A. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.05.013 · Cited by 62
Steidl, S., Wang, H., Ordonez, M., Zhang, S., & Morales, M. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13436 · Cited by 61
Somatodendritic release of endogenous dopamine: in vivo dialysis in the A10 dopamine region
Kalivas, P. W., Bourdelais, A. J., Abhold, R. H., & Abbott, L. C. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90687-3 · Cited by 60
Plasma ghrelin concentrations are positively associated with carotid artery atherosclerosis in males
Pöykkö, S. M., Kellokoski, E., Ukkola, O. H., Kauma, H., Päivänsalo, M. J., Kesäniemi, Y. A., & Hörkkö, S. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01661.x · Cited by 60
Genetic Variation of the Ghrelin Signaling System in Females With Severe Alcohol Dependence
Landgren, S., Jerlhag, E., Hallman, J., Oreland, L., Lissner, L., Strandhagen, E., Thelle, D. S., Zetterberg, H., Blennow, K., & Engel, J. A. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01236.x · Cited by 58
Synaptic Targets of 9-Tetrahydrocannabinol in the Central Nervous System
Hoffman, A. F., & Lupica, C. R. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012237 · Cited by 58
Denney, W. S., Sonnenberg, G. E., Carvajal‐Gonzalez, S., Tuthill, T., & Jackson, V. M. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13127 · Cited by 57 · cited 1×
“The GHS-R1A-inverse agonist (PF5190457) was found to be well-tolerated and safe in healthy volunteers [96], and in a single-blind, within-subject, placebo controlled human laboratory study in heavy alcohol drinkers, it was found to significantly reduce the alcohol cue-induced craving in comparison to the placebo, whil…”
BackgroundEdvardsson, C. E., Vestlund, J., & Jerlhag, E. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174039 · Cited by 56
Šustková-Fišerová, M., Jerabek, P., Havlickova, T., Kačer, P., & Kršiak, M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3466-9 · Cited by 55
Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction
van Amsterdam, J., Talhout, R., Vleeming, W., & Opperhuizen, A. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.06.010 · Cited by 55
Edwards, A., & Abizaid, A. B. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.032 · Cited by 55
Smoking Acutely Increases Plasma Ghrelin Concentrations
Bouros, D., Tzouvelekis, A., Anevlavis, S., Doris, M., Tryfon, S., Froudarakis, M., Zournatzi, V., & Kukuvitis, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.065243 · Cited by 54
A Significant Role of the Truncated Ghrelin Receptor GHS-R1b in Ghrelin-induced Signaling in Neurons
Navarro, G., Aguinaga, D., Angelats, E., Medrano, M., Moreno, E., Mallol, J., Cortés, A., Canela, E. I., Casadó, V., McCormick, P. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.715144 · Cited by 53 · cited 1×
“, D1R), promoting profound qualitative changes in ghrelin-induced signaling [47,76,77].”
BackgroundSahin, S., Yuce, M., Alacam, H., Karabekiroglu, K., Say, G. N., & Salıs, O. (2014) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2014.940054 · Cited by 52
Kokkinos, A. D., Tentolouris, N., Kyriakaki, E., Argyrakopoulou, G., Doupis, J., Psallas, M., Kyriaki, D., & Katsilambros, N. L. (2007) · Metabolism · doi:10.1016/j.metabol.2006.11.012 · Cited by 51
Peptide YY and ghrelin predict craving and risk for relapse in abstinent smokers
al’Absi, M., Lemieux, A., & Nakajima, M. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.018 · Cited by 51
The effects of chronic food restriction on cue-induced heroin seeking in abstinent male rats
D’Cunha, T. M., Sedki, F., Macri, J., Casola, C., & Shalev, U. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2810-1 · Cited by 51
Bouhlal, S., Ellefsen, K. N., Sheskier, M. B., Singley, E., Pirard, S., Gorelick, D. A., Huestis, M. A., & Leggio, L. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.07.033 · Cited by 51
Šustková-Fišerová, M., Puskina, N., Havlickova, T., Lapka, M., Syslová, K., Pohorala, V., & Charalambous, C. (2019) · Addiction Biology · doi:10.1111/adb.12845 · Cited by 51
Self-citationWellman, P. J., Clifford, P. S., Rodriguez, J., Hughes, S., Eitan, S., Brunel, L., Fehrentz, J.-A., & Martinez, J. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.08.014 · Cited by 50
Kobeissy, F., Jeung, J., Warren, M. W., Geier, J. E., & Gold, M. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00083.x · Cited by 48
Cannabinoids enhance gastric X/A-like cells activity.
Zbucki, R. L., Sawicki, B., Hryniewicz, A., & Winnicka, M. M. (2008) · Folia Histochemica et Cytobiologica · doi:10.2478/v10042-008-0033-4 · Cited by 48
Mitoepigenetics and drug addiction
Sadakierska−Chudy, A., Frankowska, M., & Filip, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.002 · Cited by 47
Cepko, L. C. S., Selva, J. A., Merfeld, E., Fimmel, A. I., Goldberg, S. A., & Currie, P. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.030 · Cited by 47
Ghrelin enhances cue-induced bar pressing for high fat food
St-Onge, V., Watts, A. J., & Abizaid, A. B. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.11.005 · Cited by 47
Suchankova, P., Engel, J. A., & Jerlhag, E. (2016) · Alcohol and Alcoholism · doi:10.1093/alcalc/agv100 · Cited by 47
Effects of Cigarette Smoking on Plasma Concentration of the Appetite-Regulating Peptide Ghrelin
Koopmann, A., Bez, J., Lemenager, T., Hermann, D., Dinter, C., Reinhard, I., Hoffmann, H., Wiedemann, K., Winterer, G., & Kiefer, F. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000381834 · Cited by 45
Maric, T., Sedki, F., Ronfard, B., Chafetz, D., & Shalev, U. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00396.x · Cited by 44
Ghrelin and ghrelin receptor modulation of psychostimulant action
Wellman, P. J., Clifford, P. S., & Rodriguez, J. A. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00171 · Cited by 44
Jerabek, P., Havlickova, T., Puskina, N., Charalambous, C., Lapka, M., Kačer, P., & Šustková-Fišerová, M. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.09.013 · Cited by 44
Self-citationAono, Y., Saigusa, T., Mizoguchi, N., Iwakami, T., Takada, K., Gionhaku, N., Oi, Y., Ueda, K., Koshikawa, N., & Cools, A. R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.10.020 · Cited by 41 · cited 1×
“Increased mesolimbic GABA concentrations potentiate opioidinduced accumbens dopamine release, and GABA contributes to opioid reinforcing effects [24,191].”
BackgroundThe Growth Hormone Secretagogue Receptor (Ghs-R)
Laviano, A., Molfino, A., Rianda, S., & Fanelli, F. R. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803216906 · Cited by 41 · cited 1×
“However, the functional role of GHS-R1B still remains much less explored [74,78,79].”
BackgroundKoopmann, A., Schuster, R., & Kiefer, F. (2016) · Biological Psychology · doi:10.1016/j.biopsycho.2016.12.012 · Cited by 41 · cited 2×
“As previously mentioned, the most advanced and extensive research of alcohol-ghrelin relationships, including an initial clinical research of the potential utilization of ghrelin antagonism for alcohol addiction therapy, has been described in-detail in complex, up-to-date reviews [26,93].”
BackgroundKalafateli, A. L., Vallöf, D., Jörnulf, J. W., Heilig, M. A., & Jerlhag, E. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.12.005 · Cited by 41
Crowley, W. R., Ramoz, G., Keefe, K. A., Torto, R., Kalra, S. P., & Hanson, G. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.11.037 · Cited by 40
Ghrelin amplifies the nicotine-induced dopamine release in the rat striatum
Palotai, M., Bagosi, Z., Jászberényi, M., Csabafi, K., Dochnal, R., Manczinger, M., Telegdy, G., & Szabó, G. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.014 · Cited by 40 · cited 3×
“In vitro experiment using rat brain slices revealed that acyl-ghrelin amplified the nicotine-induced dopamine release in the striatum [85].”
BackgroundResultJang, J. K., Kim, W. Y., Cho, B. R., Lee, J. W., & Kim, J. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.03.049 · Cited by 40
Schuette, L. M., Gray, C. C., & Currie, P. J. (2013) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2013.38060 · Cited by 39
Alen, F., Crespo, I., Ramírez-López, M. T., Jagerovic, N., Goya, P., de Fonseca, F. R., de Heras, R. G., & Orio, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060918 · Cited by 36
Kroemer, N. B., Wuttig, F., Bidlingmaier, M., Zimmermann, U. S., & Smolka, M. N. (2014) · Addiction Biology · doi:10.1111/adb.12167 · Cited by 34
Ypsilantis, P., Πολίτου, Μ., Anagnostopoulos, C., Tsigalou, C., Kambouromiti, G. L., Kortsaris, A., & Simopoulos, C. E. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts113 · Cited by 33
Suchankova, P., Nilsson, S., von der Pahlen, B., Santtila, P. O., Sandnabba, K. N., Johansson, A., Jern, P., Engel, J. A., & Jerlhag, E. (2015) · Addiction Biology · doi:10.1111/adb.12277 · Cited by 33
Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens
Šustková-Fišerová, M., Jerabek, P., Havlickova, T., Syslová, K., & Kačer, P. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4119-3 · Cited by 33
Prospects for pharmacotherapies to treat alcohol use disorder: an update on recent human studies
Farokhnia, M., Browning, B. D., & Leggio, L. (2019) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000519 · Cited by 33
Navarro, G., Rea, W. P., Quiroz, C., Moreno, E., Gomez, D. M., Wenthur, C. J., Casadó, V., Leggio, L., Hearing, M. C., & Ferré, S. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1151-21.2021 · Cited by 32 · cited 3×
“Furthermore, another variant of the ghrelin receptor, GHS-R1B, forms heterodimers/oligomeric complexes with the GHS-R1A and acts as a dual modulator of its functions [58,76].”
Background
Cited by
Sahafi, O. H., Sardari, M., Alijanpour, S., & Rezayof, A. (2023) · Brain Sciences · doi:10.3390/brainsci13050815 · Cited by 39
“Cont.”
Etxandi, M., Baenas, I., Mora‐Maltas, B., Granero, R., Fernández‐Aranda, F., Tovar, S. A., Solé‐Morata, N., Lucas, I., Casado, S., Gómez‐Peña, M., et al. (2022) · Nutrients · doi:10.3390/nu14235084 · Cited by 16
“Noticeably, ghrelin up-regulation has been described in SUDs, which positively correlates with craving, abstinence, and relapse [17–19].”
BackgroundInfluentialExogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Tunagur, E. M. K., Yazıcı, A. B., Güzel, D., Tunagür, M. T., Ermiş, Ç., Suda, M. A., & Yazıcı, E. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109577 · Cited by 9
Orellana, E. R., Horvath, N., Farokhnia, M., Leggio, L., & Hajnal, A. S. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.07.019 · Cited by 9
Metadata
- Authors
- Sustkova-Fiserova, M., Charalambous, C., Khryakova, A., Certilina, A., Lapka, M., & Šlamberová, R.
- Affiliations
- Department of Pharmacology, Third Faculty of Medicine, Charles University, Ruska 87, 100 00 Prague, Czech Republic
- Charles University (CZ)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-01-11
- Volume
- 23
- Issue
- 2
- Pages
- 761
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8776007
- OpenAlex
- W4206420944
- Semantic Scholar
- aa8b6baae25d8dd94aa269e1d610480af54eb54f
- Cited by
- 12
- References
- 234
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 3
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Univerzita Karlova v Praze (260533/SVV/2021, PROGRES Q35)
- Grantová Agentura České Republiky (GA21-30795S)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- ghrelin, GHS-R1a, growth hormone secretagogue receptor, drug addiction, nicotine dependence, opioid use disorder, stimulant use disorder, relapse prevention, addiction pharmacotherapy, genetic variation
- MeSH terms
- Clinical Studies as Topic, Central Nervous System Stimulants, Animals, Disease Models, Animal, Disease Susceptibility, Humans, Nicotine, Reinforcement, Psychology, Signal Transduction, Biomarkers, Substance-Related Disorders, Genetic Predisposition to Disease, Ghrelin, Receptors, Ghrelin, Tobacco Use
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.